Jill C. Milne

Insider Reports History

Entity
Individual
Location
C/O Catabasis Pharmaceuticals, Inc., One Kendall Sq., Bldg. 1400 E, Ste.B14202, Cambridge, MA
Signature
/s/ Noah Clauser, as attorney-in-fact for Jill C. Milne
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jill C. Milne:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Astria Therapeutics, Inc. CEO and President, Director Stock Option (Right to Buy) 535K Feb 8, 2024 Direct

Insider Reports Filed by Jill C. Milne

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ATXS Astria Therapeutics, Inc. Feb 8, 2024 1 $0 4 Feb 12, 2024 CEO and President, Director
ATXS Astria Therapeutics, Inc. Jun 2, 2023 1 $0 4 Jun 6, 2023 CEO and President, Director
ATXS Astria Therapeutics, Inc. Mar 1, 2022 1 $0 4 Mar 3, 2022 CEO and President, Director
ATXS CATABASIS PHARMACEUTICALS INC Jun 2, 2021 1 $0 4 Jun 2, 2021 CEO and President, Director